Sweden · Delayed Price · Currency is SEK NGM:MEDFIN Statistics
Total Valuation
NGM:MEDFIN has a market cap or net worth of SEK 29.17 million. The enterprise value is 23.90 million.
| Market Cap | 29.17M |
| Enterprise Value | 23.90M |
Important Dates
The next estimated earnings date is Friday, November 27, 2026.
| Earnings Date | Nov 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NGM:MEDFIN has 23.33 million shares outstanding. The number of shares has increased by 43.68% in one year.
| Current Share Class | 23.25M |
| Shares Outstanding | 23.33M |
| Shares Change (YoY) | +43.68% |
| Shares Change (QoQ) | +12.78% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 2.16.
| PE Ratio | 2.16 |
| Forward PE | n/a |
| PS Ratio | 13.27 |
| PB Ratio | 1.71 |
| P/TBV Ratio | 1.93 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 13.06 |
| EV / Sales | 10.87 |
| EV / EBITDA | 10.26 |
| EV / EBIT | 10.89 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.82, with a Debt / Equity ratio of 0.04.
| Current Ratio | 0.82 |
| Quick Ratio | 0.81 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.11 |
| Debt / FCF | -0.23 |
| Interest Coverage | 14.09 |
Financial Efficiency
Return on equity (ROE) is 8.58% and return on invested capital (ROIC) is 14.61%.
| Return on Equity (ROE) | 8.58% |
| Return on Assets (ROA) | 11.18% |
| Return on Invested Capital (ROIC) | 14.61% |
| Return on Capital Employed (ROCE) | 30.89% |
| Weighted Average Cost of Capital (WACC) | 10.63% |
| Revenue Per Employee | 732,717 |
| Profits Per Employee | 609,977 |
| Employee Count | 3 |
| Asset Turnover | 0.07 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.71% in the last 52 weeks. The beta is 1.01, so NGM:MEDFIN's price volatility has been similar to the market average.
| Beta (5Y) | 1.01 |
| 52-Week Price Change | -64.71% |
| 50-Day Moving Average | 1.25 |
| 200-Day Moving Average | 2.30 |
| Relative Strength Index (RSI) | 57.55 |
| Average Volume (20 Days) | 17,008 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NGM:MEDFIN had revenue of SEK 2.20 million and earned 1.83 million in profits. Earnings per share was 0.58.
| Revenue | 2.20M |
| Gross Profit | 926,203 |
| Operating Income | 5.46M |
| Pretax Income | 1.83M |
| Net Income | 1.83M |
| EBITDA | 5.60M |
| EBIT | 5.46M |
| Earnings Per Share (EPS) | 0.58 |
Balance Sheet
The company has 5.71 million in cash and 624,000 in debt, with a net cash position of 5.08 million or 0.22 per share.
| Cash & Cash Equivalents | 5.71M |
| Total Debt | 624,000 |
| Net Cash | 5.08M |
| Net Cash Per Share | 0.22 |
| Equity (Book Value) | 17.05M |
| Book Value Per Share | 0.74 |
| Working Capital | -1.65M |
Cash Flow
| Operating Cash Flow | -2.74M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 133,570 |
| Net Borrowing | -928,000 |
| Free Cash Flow | -2.74M |
| FCF Per Share | -0.12 |
Margins
Gross margin is 42.14%, with operating and profit margins of 248.46% and 83.25%.
| Gross Margin | 42.14% |
| Operating Margin | 248.46% |
| Pretax Margin | 83.25% |
| Profit Margin | 83.25% |
| EBITDA Margin | 254.54% |
| EBIT Margin | 248.46% |
| FCF Margin | n/a |
Dividends & Yields
NGM:MEDFIN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -43.68% |
| Shareholder Yield | -43.68% |
| Earnings Yield | 6.27% |
| FCF Yield | -9.39% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 24, 2024. It was a reverse split with a ratio of 0.0025.
| Last Split Date | Sep 24, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0025 |
Scores
NGM:MEDFIN has an Altman Z-Score of 1.12 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.12 |
| Piotroski F-Score | 3 |